1. 119TiP An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG). (December 2022) Authors: Gessner, C.; Griesinger, F.; Shah, R.; Talbot, T.; Venkateshan, S.; Vadanahalli Shankar, A.K.; Seluzhytsky, A.; Marsden, D.M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 122MO Cemiplimab (cemi) + platinum doublet chemotherapy (chemo) + ipilimumab (ipi) for first-line treatment of advanced non-small cell lung cancer (NSCLC): EMPOWER-Lung 3 part I. (December 2022) Authors: Baramidze, A.; Gogishvili, M.; Melkadze, T.; Giorgadze, D.; Penkov, K.D.; Makharadze, T.; Kalinka, E.; Nechaeva, M.; Laktionov, K.; Gessner, C.; Moreno Jaime, B.; Passalacqua, R.; Garassino, M.C.; Li, S.; Pouliot, J-F.; McGuire, K.; Quek, R.G.; Kaul, M.; Gullo, G.; Rietschel, P. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 168P Liver metastases (mets) and treatment effect of cemiplimab-based therapy: An analysis from three phase III trials (EMPOWER-Lung 1, EMPOWER-Lung 3 part 2, and EMPOWER-Cervical 1). (December 2022) Authors: Baramidze, A.; Gessner, C.; Gogishvili, M.; Sezer, A.; Makharadze, T.; Kilickap, S.; Gumus, M.; Tewari, K.S.; Monk, B.J.; de Melo, A.C.; Oaknin, A.; Li, S.; Gao, B.; Mathias, M.D.; Gullo, G.; Salvati, M.E.; Seebach, F.; Lowy, I.; Fury, M.; Rietschel, P. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3106 Open label, multicenter, prospective non-interventional study to monitor the safety and effectiveness of Bevacizumab with chemotherapy in patients with NSCLC under conditions of routine clinical practice in Germany. (September 2015) Authors: Tessen, H.W.; Linck, D.; Losem, C.; Gessner, C.; Metze, H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study. Issue 1 (January 2023) Authors: Kole, Tessa M; Vanden Berghe, Elise; Kraft, Monica; Vonk, Judith M; Nawijn, Martijn C; Siddiqui, Salman; Sun, Kai; Fabbri, Leonardo M; Rabe, Klaus F; Chung, Kian Fan; Nicolini, Gabriele; Papi, Alberto; Brightling, Chris; Singh, Dave; van der Molen, Thys; Dahlén, Sven-Erik; Agusti, Alvar; Faner, R... Journal: Lancet Issue: Volume 11:Issue 1(2023) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗